Compare Immunovant Inc. Common Stock (IMVT) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs United States Natural Gas Fund — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while United States Natural Gas Fund trades at $10.75 (market cap $522.93M). The key difference: Immunovant Inc. Common Stock is far larger — about 12.7× United States Natural Gas Fund's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and United States Natural Gas Fund for 22 Days on average.
| IMVT | UNG | |
|---|---|---|
Market Cap | $6.62B | $522.93M |
Volume | 1,131,364 | 33,973,188 |
Sector | Health | Commodities - Energy |
52-Week High | $44.96 | $16.90 |
52-Week Low | $17.03 | $9.63 |
Typical Hold Time | 0 Days | 22 Days |
Enterprise Value | $5.72B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
UNG trades at $11.03, up 2.7% today, with a bullish technical signal from moving averages and a neutral RSI. The company reported a net income of $65.15 million in 2024, though revenue was $0.00, and maintains a strong balance sheet with total assets of $790.02 million and minimal liabilities. Recent news highlights volatility in natural gas markets due to geopolitical tensions and record U.S. production.
The outlook for UNG is mixed, with bullish technicals and solid profitability offset by revenue uncertainty and market risks. Key opportunities include potential price support from geopolitical events, while risks involve natural gas price fluctuations and high production levels pressuring margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
